Communications Biology (Apr 2024)

An in vitro CRISPR screen of cell-free DNA identifies apoptosis as the primary mediator of cell-free DNA release

  • Brad. A. Davidson,
  • Adam X. Miranda,
  • Sarah C. Reed,
  • Riley E. Bergman,
  • Justin D. J. Kemp,
  • Anvith P. Reddy,
  • Morgan V. Pantone,
  • Ethan K. Fox,
  • R. Dixon Dorand,
  • Paula J. Hurley,
  • Sarah Croessmann,
  • Ben Ho Park

DOI
https://doi.org/10.1038/s42003-024-06129-1
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 15

Abstract

Read online

Abtract Clinical circulating cell-free DNA (cfDNA) testing is now routine, however test accuracy remains limited. By understanding the life-cycle of cfDNA, we might identify opportunities to increase test performance. Here, we profile cfDNA release across a 24-cell line panel and utilize a cell-free CRISPR screen (cfCRISPR) to identify mediators of cfDNA release. Our panel outlines two distinct groups of cell lines: one which releases cfDNA fragmented similarly to clinical samples and purported as characteristic of apoptosis, and another which releases larger fragments associated with vesicular or necrotic DNA. Our cfCRISPR screens reveal that genes mediating cfDNA release are primarily involved with apoptosis, but also identify other subsets of genes such as RNA binding proteins as potential regulators of cfDNA release. We observe that both groups of cells lines identified primarily produce cfDNA through apoptosis. These results establish the utility of cfCRISPR, genetically validate apoptosis as a major mediator of DNA release in vitro, and implicate ways to improve cfDNA assays.